Treatment of resistant forms of systemic lupus erythematosus with a type I interferon inhibitor in the early access program
The article presents the results of treatment of patients with systemic lupus erythematosus (SLE), who, due to resistance to traditional regimens, for the first time in the Russian Federation were included in the early access program of the type I interferon inhibitor – anifrolumab. Clinical data an...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Russo |
| Baskı/Yayın Bilgisi: |
IMA-PRESS LLC
2023-04-01
|
| Seri Bilgileri: | Современная ревматология |
| Konular: | |
| Online Erişim: | https://mrj.ima-press.net/mrj/article/view/1412 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|